White label ELPA - ClinicalTrials.eu

Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
Study on the Safety and Effectiveness of Tecaginlimab and Pembrolizumab with Radiotherapy for Patients with Metastatic Solid Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Tecaginlimab
- Pembrolizumab
Study on Ceralasertib and Durvalumab for Patients with Advanced Melanoma Resistant to PD-(L)1 Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
Study Comparing Degarelix and Drug Combination with Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials

Not recruiting

3 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
+1
Study on the Effect of Eplerenone on Arterial Stiffness in Patients One Year After Kidney Transplant

Not recruiting

3 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
- Eplerenone
Study on the Effects of Nadroparin Calcium in Patients with Subarachnoid Hemorrhage

Not recruiting

2 1 1 1
Investigated Drugs:
- Nadroparin Calcium
Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

Not recruiting

3 1 1 1
Investigated Diseases:
- Spinal muscular atrophy
Investigated Drugs:
- Onasemnogene Abeparvovec
Study on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients

Not recruiting

3 1
Investigated Drugs:
- Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker
+1
Study on Gemtuzumab Ozogamicin and Gilteritinib for Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Not recruiting

1 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Gilteritinib
- Gemtuzumab Ozogamicin

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies